Enzyme Catalysis — AP Biology Study Guide

For: AP Biology candidates sitting AP Biology.

Covers: enzyme structure and function, activation energy reduction by biological catalysts, active site vs allosteric site, induced fit model, Michaelis-Menten kinetics, common inhibition types, and experimental measurement of reaction rate.

You should already know: Basic protein structure and folding, chemical reaction thermodynamics (activation energy, free energy change), how to interpret experimental reaction rate data.

A note on the practice questions: All worked questions in the "Practice Questions" section below are original problems written by us in the AP Biology style for educational use. They are not reproductions of past College Board / Cambridge / IB papers and may differ in wording, numerical values, or context. Use them to practise the technique; cross-check with official mark schemes for grading conventions.

1. What Is Enzyme Catalysis?

Enzyme catalysis is the increase in rate of cellular chemical reactions achieved by enzymes, which are most often globular biological protein catalysts (a small subset of biological catalysts are non-protein RNA molecules called ribozymes, which are rarely tested on the AP exam). Enzymes are not consumed in the reactions they catalyze, so a single enzyme molecule can carry out thousands of reaction cycles per second. The AP Biology CED assigns this topic ~12% of the total exam weight for Unit 3: Cellular Energetics, and it appears regularly in both multiple-choice (MCQ) and free-response (FRQ) sections, often paired with experimental design or data interpretation questions. A reaction that would take hours or days to occur spontaneously at physiological temperature and pH can complete in milliseconds when catalyzed by an enzyme, making life possible by enabling the rapid metabolic reactions required for growth, homeostasis, and reproduction. Standard notation for AP Biology denotes free enzyme as $E$, substrate as $S$, the enzyme-substrate intermediate complex as $ES$, and product as $P$, written as the reaction: $E+S\rightleftharpoons ES\to E+P$. Common synonyms for the overall process are biological catalysis and enzyme-mediated reaction kinetics.

2. Enzyme Structure and Activation Energy Reduction

All enzymes function by stabilizing the transition state of a reaction, reducing the free energy of activation ($\Delta G_A$) that must be input for reactants to form products. Critically, enzymes do not change the overall free energy change of the reaction ($\Delta G$): endergonic reactions remain endergonic, exergonic reactions remain exergonic, and only the reaction rate is altered. The defining structural feature of an enzyme is the active site: a 3D pocket or cleft on the enzyme surface formed by folding of the polypeptide chain, where the substrate binds specifically. The induced fit model, the currently accepted model for AP Biology, describes that substrate binding induces a conformational change in the enzyme that tightens the active site around the substrate, bringing reactive groups into the correct orientation to strain substrate bonds and stabilize the transition state. This updates the older lock-and-key model, which incorrectly assumed a rigid pre-formed fit between enzyme and substrate. Enzymes are highly specific, most binding only one or a small set of closely related substrates due to complementary shape and chemical properties of the active site. Common mechanisms enzymes use to lower activation energy include orienting substrates correctly, straining substrate bonds, providing a favorable microenvironment, and temporarily bonding to the substrate.

Worked Example

A researcher compares activation energy and overall free energy for a reaction with and without its specific enzyme. The uncatalyzed reaction has an activation energy of $\Delta G_A=48\text{ kJ/mol}$, and an overall free energy change of $\Delta G=-20\text{ kJ/mol}$. If the enzyme reduces activation energy by 32 kJ/mol, calculate the activation energy of the catalyzed reaction and state the overall $\Delta G$ of the catalyzed reaction.

1. Recall that enzymes only alter activation energy, not the overall free energy change of the reaction. The overall $\Delta G$ depends only on the free energy of the reactants and products, which are unchanged by adding a catalyst.
2. Calculate the catalyzed activation energy by subtracting the reduction from the uncatalyzed value: $\Delta G_{A(\text{catalyzed})}=48\text{ kJ/mol}-32\text{ kJ/mol}=16\text{ kJ/mol}$
3. Confirm the overall $\Delta G$ is unchanged, as enzymes do not affect reaction thermodynamics.
4. Final result: Catalyzed activation energy = 16 kJ/mol, overall $\Delta G=-20\text{ kJ/mol}$.

Exam tip: On FRQs comparing catalyzed and uncatalyzed reactions, always explicitly state that $\Delta G$ is unchanged, even if the question only asks for activation energy. This is a common 1-point free response grading requirement.

3. Factors Affecting Enzyme Activity and Michaelis-Menten Kinetics

Enzyme activity depends entirely on correct 3D protein folding, so it is highly sensitive to environmental and cellular conditions. The most commonly tested factors are temperature, pH, substrate concentration, and enzyme concentration.

• Temperature: Increasing temperature increases reaction rate up to the enzyme's optimum temperature, as higher kinetic energy increases collision frequency between enzyme and substrate. Above the optimum, increased kinetic energy breaks the weak hydrogen bonds and ionic interactions that hold tertiary structure, causing denaturation (loss of shape and function) and a rapid drop in reaction rate.
• pH: Each enzyme has an optimum pH matching its native environment; pH changes alter the charge of amino acid R-groups, disrupting folding and causing denaturation.
• Reaction Kinetics: At fixed enzyme concentration, initial reaction rate ($v_0$) increases with substrate concentration until it hits a maximum rate $V_{max}$, when all active sites are permanently saturated with substrate. The Michaelis constant $K_m$ is defined as the substrate concentration when $v_0=\frac{1}{2}{V}_{max}$, and it measures enzyme affinity for substrate: lower $K_m$ = higher affinity. The Michaelis-Menten equation is: $$v_0=\frac{V_{max}[S]}{K_m+[S]}$$

Worked Example

The enzyme amylase breaks down starch into glucose. Researchers measure $V_{max}=12\mu mol/min$ and $K_m=0.4\text{ mM}$ for human salivary amylase. What is the initial reaction rate when starch concentration is 1.2 mM?

1. Identify all known values: $V_{max}=12\mu mol/min$, $K_m=0.4\text{ mM}$, $[S]=1.2\text{ mM}$.
2. Plug values into the Michaelis-Menten equation: $v_0=\frac{(12\mu mol/min)(1.2mM)}{0.4mM+1.2mM}$
3. Calculate numerator: $12\times 1.2=14.4$; denominator: $0.4+1.2=1.6$.
4. Solve: $v_0=14.4/1.6=9\mu mol/min$.
5. Interpretation: The $K_m$ of 0.4 mM means amylase reaches half-maximal rate at 0.4 mM starch, indicating high affinity for its substrate.

Exam tip: When asked why a reaction rate plateaus at high substrate concentration, always state it is due to active site saturation (all enzyme active sites are occupied), not denaturation. This is the most common MCQ distractor for this topic.

4. Enzyme Inhibition Types

Enzyme inhibitors are molecules that reduce enzyme activity, and are divided into two main categories tested on the AP exam: competitive and non-competitive.

• Competitive Inhibition: Inhibitors are structurally similar to the substrate and bind directly to the enzyme's active site, competing with substrate for binding. Competitive inhibition can be overcome by increasing substrate concentration, which outcompetes the inhibitor for active sites. Kinetically, competitive inhibition does not change $V_{max}$ (at very high substrate concentration, all active sites are still occupied by substrate) but increases $K_m$ (higher substrate concentration is needed to reach half-maximal rate).
• Non-competitive Inhibition: Inhibitors bind to an allosteric site, a site on the enzyme separate from the active site. This binding induces a conformational change that alters the shape of the active site, making it non-functional. Non-competitive inhibition cannot be overcome by increasing substrate concentration, because the inhibitor does not compete for the active site. Kinetically, non-competitive inhibition decreases $V_{max}$ (fewer functional enzymes are available) but does not change $K_m$ (the remaining functional active sites have the same affinity for substrate). Allosteric regulation, a common form of metabolic control, describes the binding of regulatory molecules (activators or inhibitors) to allosteric sites to control enzyme activity, often in feedback inhibition where the end product of a pathway inhibits the first enzyme in the pathway.

Worked Example

A researcher tests two new inhibitors of the enzyme catalase, and obtains the following kinetic parameters compared to uninhibited enzyme:

• Inhibitor A: $V_{max}=80\mu mol/s$ (same as uninhibited), $K_m=1.8\text{ mM}$ (uninhibited $K_m=0.5\text{ mM}$)
• Inhibitor B: $K_m=0.5\text{ mM}$ (same as uninhibited), $V_{max}=30\mu mol/s$ (uninhibited $V_{max}=80\mu mol/s$) Identify the type of each inhibitor and justify your answer.

1. Recall the kinetic signatures for each inhibition type.
2. For Inhibitor A: $V_{max}$ is unchanged, but $K_m$ is increased. This matches competitive inhibition: the inhibitor competes for the active site, so higher substrate concentration is required to reach half-maximal rate (increased $K_m$), but maximum rate is still reached at high enough substrate concentration (unchanged $V_{max}$).
3. For Inhibitor B: $K_m$ is unchanged, but $V_{max}$ is decreased. This matches non-competitive inhibition: the inhibitor binds an allosteric site, so the remaining functional active sites retain their original affinity for substrate (unchanged $K_m$), but fewer functional enzymes are available, so maximum rate is lower (decreased $V_{max}$).
4. Final classification: Inhibitor A = competitive inhibitor; Inhibitor B = non-competitive inhibitor.

Exam tip: When asked to identify inhibition type from a Lineweaver-Burk plot, remember competitive inhibitors change the x-intercept (which equals $-1/K_m$) and non-competitive inhibitors change the y-intercept (which equals $1/V_{max}$).

5. Common Pitfalls (and how to avoid them)

• Wrong move: Claiming that enzymes change the overall free energy change ($\Delta G$) of a reaction to make it spontaneous. Why: Students confuse the effect on activation energy with effect on overall thermodynamics, because enzymes make slow reactions happen fast enough to be observable. Correct move: Always remember enzymes only change reaction rate by lowering activation energy; the overall $\Delta G$ is determined by the free energy of reactants and products, which enzymes do not alter.
• Wrong move: Claiming that increasing temperature always increases enzyme reaction rate. Why: Students remember temperature increases molecular motion, so they generalize this to all temperature ranges. Correct move: Always state that rate increases with temperature only up to the enzyme's optimum; above that, denaturation occurs and rate drops sharply.
• Wrong move: Claiming that competitive inhibition decreases $V_{max}$ because it blocks active sites. Why: Students forget that at very high substrate concentrations, substrate can outcompete the inhibitor for all active sites. Correct move: For competitive inhibition, remember $V_{max}$ stays the same and only $K_m$ increases; $V_{max}$ only decreases when the number of functional active sites is permanently reduced, as in non-competitive inhibition.
• Wrong move: Confusing the induced fit model with the lock-and-key model, claiming enzymes have a rigid fixed active site shape before substrate binding. Why: The older lock-and-key model is often introduced first, so students mix the two up. Correct move: On any exam question asking about enzyme binding, default to the induced fit model, which states substrate binding triggers a conformational change that tightens the active site around the substrate.
• Wrong move: Confusing active site saturation (plateau in rate vs substrate concentration) with denaturation. Why: Both cause a plateau or drop in rate, leading to confusion. Correct move: If the x-axis is substrate concentration (fixed enzyme concentration), the plateau is due to saturation; if the x-axis is temperature/pH, the drop after the optimum is due to denaturation.
• Wrong move: Claiming all allosteric binding is inhibitory. Why: Most textbook examples focus on inhibitory regulation, leading students to forget activation. Correct move: Remember allosteric regulation can be either activating or inhibiting; allosteric activators stabilize the active form of an enzyme to increase activity.

6. Practice Questions (AP Biology Style)

Question 1 (Multiple Choice)

Pepsin is a digestive enzyme that functions in the human stomach, which has a resting pH of ~2. Which of the following descriptions correctly matches the expected reaction rate profile of pepsin as pH increases from 1 to 10? A) Reaction rate increases linearly from pH 1 to pH 10 B) Reaction rate peaks at pH 2, then decreases steadily as pH increases above 2 C) Reaction rate is constant from pH 1 to 10, because pH does not affect enzyme activity D) Reaction rate peaks at pH 7, then decreases as pH moves away from 7 in either direction

Worked Solution: Each enzyme has an optimum pH matching the pH of its native environment. Pepsin evolved to function in the acidic stomach, so its optimum pH is ~2. pH increases above 2 alter the charge of pepsin's amino acid R-groups, disrupting folding and reducing activity. Option A is incorrect because pH affects enzyme folding and activity. Option C is incorrect because pH directly alters enzyme structure and function. Option D describes the profile of a cytoplasmic enzyme with optimum pH 7, not pepsin. The only correct profile is option B. Correct answer: B.

Question 2 (Free Response)

A researcher investigates the effect of a new fungal toxin on the activity of the enzyme pyruvate kinase, which catalyzes the final step of glycolysis. The researcher measures initial reaction rate at different pyruvate concentrations with and without the toxin, with results shown below:

(a) Identify the $V_{max}$ for uninhibited and toxin-treated pyruvate kinase. What is the effect of the toxin on $V_{max}$? (b) The $K_m$ of uninhibited pyruvate kinase is 0.2 mM. Is the toxin-treated $K_m$ the same, higher, or lower than the uninhibited value? Justify your answer. (c) Based on your results, identify the type of inhibitor the toxin is, and predict whether high pyruvate concentration will overcome the inhibition. Justify your prediction.

Worked Solution: (a) $V_{max}$ is the maximum initial rate reached at high substrate concentration when all active sites are saturated. For uninhibited enzyme, the rate plateaus at $50\mu mol/min$, so $V_{max(\text{uninhibited})}=50\mu mol/min$. For toxin-treated enzyme, the rate plateaus at $20\mu mol/min$, so $V_{max(\text{toxin})}=20\mu mol/min$. The toxin reduces $V_{max}$ by 30 $\mu mol/min$ compared to control. (b) $K_m$ is defined as the substrate concentration that gives a rate equal to half of $V_{max}$. For toxin-treated enzyme, $\frac{1}{2}{V}_{max}=\frac{1}{2}(20)=10\mu mol/min$. The data shows a rate of 10 $\mu mol/min$ is reached at 0.2 mM pyruvate, the same as the uninhibited enzyme. Therefore, the toxin-treated $K_m$ is identical to the uninhibited $K_m$. (c) The toxin is a non-competitive inhibitor, because it decreases $V_{max}$ but leaves $K_m$ unchanged. High pyruvate concentration will not overcome the inhibition: the toxin binds an allosteric site separate from the active site, so it does not compete with pyruvate for binding. The conformational change induced by toxin binding permanently inactivates a subset of enzyme molecules, so even high substrate concentration cannot restore the original maximum rate.

Question 3 (Application / Real-World Style)

The anticoagulant drug warfarin acts as an irreversible competitive inhibitor of the enzyme vitamin K epoxide reductase, which is required to activate clotting factors in the blood. Warfarin binds covalently to the enzyme's active site, permanently inactivating bound enzyme molecules. A patient has a dose of warfarin that inactivates 60% of their vitamin K epoxide reductase. The original $V_{max}$ of the patient's enzyme was 25 nmol/min. Calculate the new $V_{max}$ after warfarin treatment, and predict the effect on $K_m$. Explain why this reduces clotting risk in the patient.

Worked Solution:

1. Irreversible inactivation of enzyme molecules reduces the concentration of functional enzyme, and $V_{max}$ is proportional to the concentration of functional enzyme.
2. If 60% of enzyme is inactivated, 40% remains functional. New $V_{max}=0.4\times 25nmol/min=10nmol/min$.
3. $K_m$ is unchanged, because the remaining functional active sites have the same affinity for their substrate as before inactivation.
4. In context: Vitamin K epoxide reductase is required to produce activated clotting factors that enable blood clotting. Reduced $V_{max}$ of the enzyme lowers the concentration of activated clotting factors, reducing the risk of dangerous blood clots forming in vessels.

7. Quick Reference Cheatsheet

8. What's Next

Enzyme catalysis is the foundational prerequisite for all remaining topics in Unit 3: Cellular Energetics. Next, you will apply your understanding of enzyme function, rate regulation, and inhibition to study cellular respiration and photosynthesis, the two core enzyme-mediated metabolic pathways that produce ATP and organic carbon for all cells. Without mastering enzyme structure, kinetics, and inhibition, you will not be able to interpret experimental data on metabolic pathways or explain how cells regulate energy production to maintain homeostasis. Beyond Unit 3, enzyme catalysis is also core to cell signaling (phosphorylation cascades rely on enzyme activity) and biotechnology (PCR, restriction digests, and gene editing all depend on controlled enzyme function). Follow-up topics for further study: Cellular Respiration Photosynthesis Cell Signaling Biotechnology and Recombinant DNA